Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07294300
What this trial is testing

A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies

Who this might be right for
Relapsed/Refractory Hematological Malignancies
Qilu Pharmaceutical Co., Ltd. 124
Testing effectiveness (Phase 2)Study completedNCT00429416
What this trial is testing

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)Study completedNCT00987987
What this trial is testing

Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion

Who this might be right for
Hematologic NeoplasmsRelapse
Assistance Publique - Hôpitaux de Paris 21
Early research (Phase 1)Study completedNCT01607892
What this trial is testing

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Who this might be right for
Hematological Malignancies
Karyopharm Therapeutics Inc 286
Testing effectiveness (Phase 2)Ended earlyNCT03769532
What this trial is testing

MRD-guided Treatment in NPM1mut AML Patients

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 26
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Very early researchUnknownNCT06393335
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
The Children's Hospital of Zhejiang University School of Medicine 36
Early research (Phase 1)Study completedNCT04283097
What this trial is testing

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects

Who this might be right for
Hematological Malignancies
Kangpu Biopharmaceuticals, Ltd. 30
Early research (Phase 1)Looking for participantsNCT06462365
What this trial is testing

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Who this might be right for
Hematologic MalignancyGvHDGVHD,Acute+8 more
Tr1X, Inc. 36
Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Testing effectiveness (Phase 2)Study completedNCT00862719
What this trial is testing

Sitagliptin Umbilical Cord Blood Transplant Study

Who this might be right for
Leukemia, Myeloid, AcuteAcute Lymphoblastic LeukemiaMyelodysplasia+2 more
Indiana University 29
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT01807598
What this trial is testing

Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia

Who this might be right for
Aggressive Systemic MastocytosisMast Cell LeukemiaSystemic Mastocytosis
Jason Robert Gotlib 10
Not applicableStudy completedNCT06122311
What this trial is testing

Drug Nephrotoxicity Amelioration by N-acetylcysteine

Who this might be right for
Drug-Induced Nephropathy
Helwan University 100
Early research (Phase 1)Study completedNCT00595686
What this trial is testing

Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies

Who this might be right for
Hematologic Neoplasms
Esanex Inc. 25
Testing effectiveness (Phase 2)WithdrawnNCT01554254
What this trial is testing

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Who this might be right for
Cord Blood TransplantHematologic MalignancyInherited Metabolic Disease
Tarix Pharmaceuticals
Early research (Phase 1)Ended earlyNCT02683395
What this trial is testing

PLX51107 in Advanced Malignancies

Who this might be right for
Solid TumorsAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
Plexxikon 50
Not applicableStudy completedNCT00892502
What this trial is testing

Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?

Who this might be right for
Hematological DiseasesHematological MalignanciesBlood Diseases+3 more
Copenhagen University Hospital at Herlev 50
Not applicableStudy completedNCT00948207
What this trial is testing

Online and Narrative Interventions for Advanced Cancer Patients

Who this might be right for
Metastatic Cancer
University of Wisconsin, Madison 117
Early research (Phase 1)Study completedNCT01280240
What this trial is testing

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

Who this might be right for
Patients With Chemotherapy Induced Anemia (CIA)
Pharmacosmos A/S 11
Next Page